Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) CEO Mac Armstrong sold 11,484 shares of the business’s stock in a transaction that occurred on Wednesday, January 28th. The shares were sold at an average price of $119.88, for a total value of $1,376,701.92. Following the sale, the chief executive officer owned 91,737 shares of the company’s stock, valued at approximately $10,997,431.56. This represents a 11.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Mac Armstrong also recently made the following trade(s):
- On Wednesday, January 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $129.00, for a total transaction of $645,000.00.
- On Thursday, January 15th, Mac Armstrong sold 2,310 shares of Palomar stock. The shares were sold at an average price of $130.00, for a total transaction of $300,300.00.
- On Friday, November 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The stock was sold at an average price of $122.86, for a total transaction of $614,300.00.
Palomar Trading Up 0.3%
Palomar stock opened at $123.59 on Friday. The firm has a market capitalization of $3.28 billion, a price-to-earnings ratio of 19.28 and a beta of 0.42. The firm’s fifty day moving average price is $127.65 and its two-hundred day moving average price is $123.95. Palomar Holdings, Inc. has a 1-year low of $104.47 and a 1-year high of $175.85.
More Palomar News
Here are the key news stories impacting Palomar this week:
- Neutral Sentiment: Yahoo Finance published a piece asking whether PLMR’s recent price slide creates a long‑term buying opportunity — a constructive framing for value investors but speculative. Is Palomar Holdings (PLMR) Price Slide Creating A Long Term Opportunity For Investors
- Negative Sentiment: CEO Mac Armstrong sold 11,484 shares at $119.88 (≈$1.38M); his post-sale holding is 91,737 shares (11.13% decrease). SEC filing: CEO Sale Filing
- Negative Sentiment: President Jon Christianson sold 1,991 shares at $119.88 (≈$238.7k); post-sale holding 62,985 shares (3.06% decrease). SEC filing: President Sale Filing
- Negative Sentiment: CFO T. Christopher Uchida sold 2,103 shares at $119.88 (≈$252.1k); post-sale holding 11,473 shares (15.49% decrease). SEC filing: CFO Sale Filing
- Negative Sentiment: Insider Jonathan Knutzen sold 1,535 shares at $119.88 (≈$184.0k); post-sale holding 24,809 shares (5.83% decrease). SEC filing: Insider Sale Filing
- Negative Sentiment: Insider Angela L. Grant sold 1,447 shares at $119.88 (≈$173.5k); post-sale holding 5,242 shares (21.63% decrease). SEC filing: Insider Sale Filing
Institutional Investors Weigh In On Palomar
Large investors have recently made changes to their positions in the business. Salomon & Ludwin LLC purchased a new position in shares of Palomar in the 3rd quarter worth about $25,000. Richardson Financial Services Inc. raised its position in Palomar by 210.0% in the third quarter. Richardson Financial Services Inc. now owns 217 shares of the company’s stock worth $25,000 after acquiring an additional 147 shares during the period. Allworth Financial LP raised its position in Palomar by 1,970.0% in the second quarter. Allworth Financial LP now owns 207 shares of the company’s stock worth $32,000 after acquiring an additional 197 shares during the period. Geneos Wealth Management Inc. purchased a new position in Palomar in the fourth quarter valued at about $32,000. Finally, Clearstead Advisors LLC grew its position in shares of Palomar by 31.0% during the 3rd quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock valued at $46,000 after acquiring an additional 94 shares during the period. 90.25% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the company. Weiss Ratings raised Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Keefe, Bruyette & Woods lifted their price objective on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a report on Tuesday, January 6th. JPMorgan Chase & Co. upped their target price on shares of Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 7th. Finally, Wall Street Zen raised shares of Palomar from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Six research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $159.50.
Get Our Latest Stock Report on Palomar
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Recommended Stories
- Five stocks we like better than Palomar
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
